Viewing Study NCT00453635


Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2026-04-09 @ 3:01 AM
Study NCT ID: NCT00453635
Status: TERMINATED
Last Update Posted: 2012-03-13
First Post: 2007-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients
Sponsor: Hellenic Oncology Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module